{
  "content": "Warfarin. While most patients maintain therapeutic warfarin doses, over a third of those starting concurrent amiodarone treatment experienced excessive anticoagulation within three weeks. To minimize the risk of severe and avoidable bleeding, the initiation of amiodarone should be accompanied by intensified INR monitoring, along with an expected average dose reduction of warfarin by 25–33% .",
  "source": "https://pdfs.semanticscholar.org/eda9/09ebe34c58658072d9d3a1e6db13d581c6cd.pdf?skipShowableCheck=true",
  "chunk_id": "724ec8df-b21e-4cc7-a545-9604256f4e94",
  "similarity_score": 0.27462315559387207,
  "query": "amiodarone pharmacokinetics drug interactions CYP450 beta-blockers metabolism clearance atrial fibrillation dosing",
  "rank": 34,
  "title": "Amiodarone Therapy: Updated Practical Insights",
  "authors": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărasu, B. C., Diaconu, A.-D., Sorodoc, L.",
  "year": "2024",
  "journal": "Journal of Clinical Medicine",
  "reference": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărasu, B. C., Diaconu, A.-D., & Sorodoc, L. (2024). Amiodarone therapy: Updated practical insights. Journal of Clinical Medicine, 13(20), 6094. https://doi.org/10.3390/jcm13206094",
  "doi": "10.3390/jcm13206094",
  "chunk_index": 47,
  "total_chunks": 209,
  "retrieved_at": "2025-07-24T21:58:09.739222"
}